Zu den Inhalten springen

Kontextnavigation:

  • .

Professor Dr. Justus Duyster

Medical Director of the Department of Oncology, Hematology, and Stem-Cell Transplantation

Professor Dr. Justus Duyster is one of Germany’s leading specialists in hematology and oncology. He serves as Medical Director of the Department of Oncology, Hematology, and Stem Cell Transplantation and also leads one of the country’s largest cancer centers.

After studying medicine at the University of Freiburg, Professor Duyster worked at renowned university hospitals in Germany and the United States, gaining extensive clinical and research experience in oncology and hematologic diseases.

Since 2013, he has served as Medical Director of the Comprehensive Cancer Center Freiburg (CCCF), which holds the status of a Center of Excellence, the highest designation for oncology centers in Germany. Such centers integrate advanced clinical care, scientific research, and innovative treatment approaches.

Professor Duyster combines clinical practice with an active research program focused on the molecular mechanisms of cancer development and progression, resistance to chemotherapy and targeted therapies, and the development of personalized treatment strategies. 

Areas of Expertise

  • treatment of solid tumors
  • benign and malignant diseases of the blood and bone marrow
  • disorders of blood coagulation

­

Research & Innovation

  • signal transduction of oncogenic tyrosine kinases in cancer
  • clinical development of molecular therapies for malignant diseases
  • mechanisms of resistance to chemotherapy and signal transduction inhibitors
  • cellular and noncellular immunotherapy

­­­

Professor Duyster directs the Duyster Laboratory, where his research group develops innovative therapeutic strategies.

Through cutting-edge clinical and experimental research, close interdisciplinary collaboration with other departments, and the use of state-of-the-art medical technologies, Professor Duyster and his team provide innovative, highly personalized treatment approaches based on the latest advances in biomedical science.

Department of Oncology, Hematology, and Stem-Cell Transplantation